Title | Transfecting the hard-to-transfect lymphoma/leukemia cells using a simple cationic polymer nanocomplex. |
Publication Type | Journal Article |
Year of Publication | 2012 |
Authors | Zhao N, Qi J, Zeng Z, Parekh P, Chang C-C, Tung C-H, Zu Y |
Journal | J Control Release |
Volume | 159 |
Issue | 1 |
Pagination | 104-10 |
Date Published | 2012 Apr 10 |
ISSN | 1873-4995 |
Keywords | Cell Line, Tumor, DNA, Green Fluorescent Proteins, Humans, Leukemia, Lymphoma, Plasmids, Polymers, Transfection |
Abstract | Although the development of gene delivery systems via non-viral-mediated methods is advancing rapidly, it remains a challenge to deliver plasmids into hard-to-transfect cells, such as lymphoma/leukemia cells. To develop an efficient transfection method, we formulated a simple nanocomplex by incorporating poly β-amino ester (PBAE) polymers with plasmid DNAs containing a GFP reporter gene. The formed PBAE-plasmid nanocomplexes are approximately 200nm in diameter and stable under physiological conditions, but become rapidly biodegradable when pH decreases <7.0. Cultured lymphoma/leukemia cells were used for transfection assays and resultant gene delivery rates were determined by quantifying GFP expression. Exposure of cells to the nanocomplexes composed of fractioned PBAE (>7kDa) resulted in GFP expression in 3% of cells, similar to that mediated by the standard Lipofectamine method. However, with polybrene pre-treatment, the nanocomplex could achieve GFP expression in up to 32% of lymphoma/leukemia cells, an 8-fold increase over that mediated by Lipofectamine. These findings demonstrated a simple, efficient method for in vitro gene delivery into hard-to-transfect cells. The nanocomplexes are biodegradable and have minimal cytotoxicity, suggesting the potential use for in vivo gene delivery. |
DOI | 10.1016/j.jconrel.2012.01.007 |
Alternate Journal | J Control Release |
PubMed ID | 22269663 |
PubMed Central ID | PMC3322282 |
Grant List | R01 CA151955-01 / CA / NCI NIH HHS / United States P50 CA126752 / CA / NCI NIH HHS / United States R01 CA151955 / CA / NCI NIH HHS / United States R33 CA173382 / CA / NCI NIH HHS / United States R01CA151955 / CA / NCI NIH HHS / United States R01 CA151955-02 / CA / NCI NIH HHS / United States |
Related Institute:
Molecular Imaging Innovations Institute (MI3)